254 related articles for article (PubMed ID: 28056821)
1. Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.
Sorlí L; Luque S; Segura C; Campillo N; Montero M; Esteve E; Herrera S; Benito N; Alvarez-Lerma F; Grau S; Horcajada JP
BMC Infect Dis; 2017 Jan; 17(1):11. PubMed ID: 28056821
[TBL] [Abstract][Full Text] [Related]
2. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.
Sorlí L; Luque S; Li J; Campillo N; Danés M; Montero M; Segura C; Grau S; Horcajada JP
J Infect; 2019 Sep; 79(3):253-261. PubMed ID: 31265867
[TBL] [Abstract][Full Text] [Related]
3. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
Sorli L; Luque S; Li J; Rodríguez E; Campillo N; Fernandez X; Soldado J; Domingo I; Montero M; Grau S; Horcajada JP
Molecules; 2019 Feb; 24(3):. PubMed ID: 30717123
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.
Karnik ND; Sridharan K; Jadhav SP; Kadam PP; Naidu RK; Namjoshi RD; Gupta V; Gore MS; Surase PV; Mehta PR; Gogtay JA; Thatte UM; Gogtay NJ
Eur J Clin Pharmacol; 2013 Jul; 69(7):1429-36. PubMed ID: 23508665
[TBL] [Abstract][Full Text] [Related]
6. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
[TBL] [Abstract][Full Text] [Related]
7. Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.
Horcajada JP; Sorlí L; Luque S; Benito N; Segura C; Campillo N; Montero M; Esteve E; Mirelis B; Pomar V; Cuquet J; Martí C; Garro P; Grau S
Int J Antimicrob Agents; 2016 Dec; 48(6):725-727. PubMed ID: 28128096
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.
Montero M; Horcajada JP; Sorlí L; Alvarez-Lerma F; Grau S; Riu M; Sala M; Knobel H
Infection; 2009 Oct; 37(5):461-5. PubMed ID: 19499183
[TBL] [Abstract][Full Text] [Related]
9. Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction.
Turkoglu M; Dizbay M; Ciftçi A; Aksakal FN; Aygencel G
Int J Antimicrob Agents; 2012 Feb; 39(2):142-5. PubMed ID: 22115538
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer.
Krajewski J; Bode-Böger SM; Tröger U; Martens-Lobenhoffer J; Mulrooney T; Mittelstädt H; Russlies M; Kirchner R; Knobloch JK
Int J Antimicrob Agents; 2014 Oct; 44(4):363-6. PubMed ID: 25182711
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.
Falagas ME; Kasiakou SK; Kofteridis DP; Roditakis G; Samonis G
Eur J Clin Microbiol Infect Dis; 2006 Sep; 25(9):596-9. PubMed ID: 16955249
[TBL] [Abstract][Full Text] [Related]
13. Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring.
Yamada T; Ishiguro N; Oku K; Higuchi I; Nakagawa I; Noguchi A; Yasuda S; Fukumoto T; Iwasaki S; Akizawa K; Furugen A; Yamaguchi H; Iseki K
Biol Pharm Bull; 2015; 38(9):1430-3. PubMed ID: 26155936
[TBL] [Abstract][Full Text] [Related]
14. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study.
Gómez-Junyent J; Rigo-Bonnin R; Benavent E; Soldevila L; Padullés A; Cabo X; Tubau F; Ariza J; Murillo O
Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):587-599. PubMed ID: 32440843
[TBL] [Abstract][Full Text] [Related]
17. Sudden respiratory muscle paralysis and apnea in a patient infected with multidrug-resistant Pseudomonas aeruginosa treated with intravenous colistin.
Fernández AB; Pérez M; Soto L
Int J Infect Dis; 2013 May; 17(5):e357. PubMed ID: 23266335
[No Abstract] [Full Text] [Related]
18. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
Moni M; Sudhir AS; Dipu TS; Mohamed Z; Prabhu BP; Edathadathil F; Balachandran S; Singh SK; Prasanna P; Menon VP; Patel T; Patel P; Kaye KS; Menon VP
Int J Infect Dis; 2020 Nov; 100():497-506. PubMed ID: 32781161
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis.
Durakovic N; Radojcic V; Boban A; Mrsic M; Sertic D; Serventi-Seiwerth R; Nemet D; Labar B
Intern Med; 2011; 50(9):1009-13. PubMed ID: 21532223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
